Il Dong Pharmaceutical Co Ltd Capital Reinvestment Ratio
Il Dong Pharmaceutical Co Ltd capital reinvestment ratio. Il Dong Pharmaceutical Co Ltd (249420) has a Capital Reinvestment Ratio of 0.53x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩11.28 Billion) in capital expenditures (₩5.97 Billion). See 249420 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Il Dong Pharmaceutical Co Ltd (2016–2024)
Capital reinvestment ratio of Il Dong Pharmaceutical Co Ltd from 2016 to 2024. This chart tracks Il Dong Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 6 annual periods. See 249420 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Il Dong Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2016–2024)
Il Dong Pharmaceutical Co Ltd capital reinvestment ratio by year from 2016 to 2024. For the full cash flow conversion analysis, see 249420 cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.50x | ₩28.29 Billion | ₩14.05 Billion | ▼ -33.0% |
| 2020 | 0.74x | ₩19.37 Billion | ₩14.35 Billion | ▲ +154.2% |
| 2019 | 0.29x | ₩41.37 Billion | ₩12.06 Billion | ▲ +28.8% |
| 2018 | 0.23x | ₩66.65 Billion | ₩15.09 Billion | ▼ -0.2% |
| 2017 | 0.23x | ₩73.72 Billion | ₩16.73 Billion | ▼ -26.6% |
| 2016 | 0.31x | ₩45.98 Billion | ₩14.22 Billion | — |